AI-Powered rehab at home could help MS patients move better
NCT ID NCT07310914
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether an advanced telerehabilitation system, which uses AI to give instant feedback, can improve mobility in people with multiple sclerosis. 94 participants will either use the smart system or follow paper-based exercises at home. The goal is to see if this technology can help those who cannot or prefer not to travel to a clinic for exercise therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
telerehabilitation program
What this could lead to
If successful, this could offer a convenient, home-based exercise option for people with MS who cannot easily travel to a clinic.
What could go wrong
This is a small, early-phase trial (94 people) testing a behavioral intervention, so results may not apply to everyone with MS. The technology may not be better than simple paper exercises.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MS Ireland
Dublin, Ireland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tel Aviv University
Tel Aviv, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Danish MS Hospitals, Haslev
Haslev, 4690, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Danish MS Hospitals, Ry
Ry, 8660, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Cagliari
Cagliari, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••